Three BCI Architectures, One Regulatory Finish Line: What the 2025 Trial Data Actually Shows
6 min readNeuralink, Synchron, and Precision Neuroscience have each produced clinical safety data in the past 18 months — but with three different architectures and three different regulatory bets. Here is what the actual trial data shows, and what to watch as the field approaches its first PMA filing.